Sandbox/table: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Guillermo Rodriguez Nava (talk | contribs)
nocaptcha
703 edits
Guillermo Rodriguez Nava (talk | contribs)
nocaptcha
703 edits
Line 15: Line 15:


{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 30%;"
{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 30%;"
|+ '''Laboratory findings'''
|+ '''Ebola virus strains identified'''
|-
|-
! style="width: 75px; background: #4479BA; text-align: center;"|{{fontcolor|#FFF|Test}}
! style="width: 100px; background: #4479BA; text-align: center;"|{{fontcolor|#FFF|Ebola virus strain}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Findings}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Place of discovery}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Date}}
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[White blood cells]] count'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Sudan ebolavirus'''
| style="background: #DCDCDC; padding: 5px;"| Leucopenia (1000 cells/μL)<br>Lymphopenia<br>Neutrophilia
| style="background: #DCDCDC; padding: 5px;"| Sudan
| style="background: #F5F5F5; padding: 5px;"| Between June and November 1976
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Blood smear]]'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Zaire ebolavirus'''
| style="background: #DCDCDC; padding: 5px;"| [[Left shift]]<br>Atypical [[lymphocytes]]
| style="background: #DCDCDC; padding: 5px;"| Yambuku, Democratic Republic of the Congo (formerly Zaire)
| style="background: #F5F5F5; padding: 5px;"| Between August and November 1976
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Liver function tests]]'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Reston ebolavirus'''
| style="background: #DCDCDC; padding: 5px;"| Raised [[aspartate aminotransferase]]<br>Raised[[alanine aminotransferase]]<br>Extended [[prothrombin time]]<br>Extended[[partial thromboplastin time]]
| style="background: #DCDCDC; padding: 5px;"| Reston, Virginia, US.
 
| style="background: #F5F5F5; padding: 5px;"| November 1989
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Proteins]]'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Ivory Coast ebolavirus'''
| style="background: #DCDCDC; padding: 5px;"| [[Hyperproteinemia]]
| style="background: #DCDCDC; padding: 5px;"| Tai Forest, Cote d'Ivoire.
 
| style="background: #F5F5F5; padding: 5px;"| November 1994
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Urinalysis]]'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Bundibugyo ebolavirus'''
| style="background: #DCDCDC; padding: 5px;"| [[Proteinuria]]
| style="background: #DCDCDC; padding: 5px;"| Bundibugyo District, Uganda
 
| style="background: #F5F5F5; padding: 5px;"|  November 2007
|}
|}


Revision as of 19:20, 23 June 2014

The following table contains the main risk factors for CDI:[1][2][3][2][2]

Alterations in the coagulation system
Consumption of clotting factors
Increased concentrations of fibrin degradation products
Disseminated intravascular coagulation

table

Ebola virus strains identified
Ebola virus strain Place of discovery Date
Sudan ebolavirus Sudan Between June and November 1976
Zaire ebolavirus Yambuku, Democratic Republic of the Congo (formerly Zaire) Between August and November 1976
Reston ebolavirus Reston, Virginia, US. November 1989
Ivory Coast ebolavirus Tai Forest, Cote d'Ivoire. November 1994
Bundibugyo ebolavirus Bundibugyo District, Uganda November 2007

table

Countries with a reported prevalence <15% of H. pylori resistance to clarithromycin
Diagnostic test North America South America Middle East Far East
ELISA (serology) detects:
  • Viral Antigen
  • IgM and IgG antibody | hol

† There is a reported prevalence of 15% in the Northeast of the US.

  1. ↑ Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
  2. ↑ 2.0 2.1 2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
  3. ↑ Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox/table&oldid=981199"